BCL2 and B-cell chronic lymphocytic leukemia: Venetoclax is a potent, selective inhibitor of B-cell lymphoma 2 (BCL-2) that is a key regulator of apoptosis and is used for the management of chronic lymphocytic leukemia (CLL) either alone or in combination.